合力泰(002217.SZ):股東文開福合計被動減持2160.55萬股
格隆匯6月16日丨合力泰(002217.SZ)公吿,2021年6月16日,公司接到公司持股5%以上股東文開福吿知,獲知文開福所持公司股份發生了被動減持。此次被動減持110.55萬股,佔公司總股本的0.04%。
公吿顯示,根據《山東省淄博市中級人民法院協助執行通知書》<(2021)魯03執113號>,天風證券深圳深南大道華潤城證券營業部擬將文開福持有的公司股票2210萬股賣出,並於2021年5月17至2021年6月16日合計賣出公司股票2160.55萬股,截至2021年6月16日,尚有49.45萬股未執行完畢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.